Pharvaris Income Statement (2019-2026) | PHVS

Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
0.01B-0.01B0.07B-0.02B0.01B-0.01B0.10B-0.01B0.02B-0.02B0.12B-0.02B0.02B-0.03B0.18B-0.03B0.03B-0.03B0.25B-0.04B
Selling, General & Administrative (Quarter)
-0.01B-0.01B0.04B-0.01B-0.01B-0.01B0.05B-0.01B-0.01B-0.01B0.06B-0.01B-0.01B-0.01B0.09B-0.01B-0.01B-0.01B0.09B-0.02B
Restructuring Costs (Quarter)
-0.00B948.79-0.00B-0.00B0.00B
Other Operating Expenses (Quarter)
-0.02B0.000.00B0.00-0.03B-948.790.00B-0.03B0.00B0.00-0.05B-0.00B-0.07B0.00
Operating Expenses (Quarter)
-0.02B-0.02B0.11B-0.02B-0.02B-0.02B0.15B-0.02B-0.02B-0.03B0.18B-0.03B-0.04B-0.04B0.26B-0.04B-0.05B-0.05B0.34B-0.05B
Operating Income (Quarter)
-0.02B-0.02B-0.05B-0.02B-22571.90B-0.08B-22621.78B-0.03B-0.04B-0.14B-44375124102.22B-46.37-0.20B-0.05B
EBIT (Quarter)
-0.02B-0.02B-0.05B-0.02B-0.01B-22571.90B-0.08B-22621.78B-0.02B-0.03B-0.03B-0.03B-0.03B-0.04B-0.14B-44375124102.22B-0.05B-46.37-0.20B-0.05B
Non-operating items
Other Non Operating Income (Quarter)
-0.00B0.01B0.02B0.00B-0.02B-0.01B0.04B-0.00B0.00B-0.00B-0.00B-0.00B-3388.46B3,455.58B0.01B0.01B13,585.23B-14030.42B-0.03B
Non Operating Income (Quarter)
-0.00B0.01B-0.01B0.00B0.01B0.01B-0.03B-0.00B0.00B0.00B-0.01B-0.00B0.01B-0.00B0.02B-0.00B-0.01B0.00B0.00B0.00B
Net income details
EBT (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.01B-0.01B-0.04B-0.02B-0.02B-0.03B-0.03B-0.03B-0.03B-0.05B-0.04B-0.05B-0.05B-0.04B-0.20B-0.05B
Profit After Tax (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.01B-0.01B-0.04B-0.02B-0.02B-0.03B-0.04B-0.03B-0.03B-0.05B-0.04B-0.05B-0.05B-0.04B-0.05B-0.05B
Income from Continuing Operations (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.01B-0.01B-0.04B-0.02B-0.02B-0.03B-0.03B-0.03B-0.03B-0.05B-0.04B-0.05B-0.05B-0.04B-0.20B-0.05B
Consolidated Net Income (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.01B-0.01B-0.04B-0.02B-0.02B-0.03B-0.03B-0.03B-0.03B-0.05B-0.04B-0.05B-0.05B-0.04B-0.20B-0.05B
Income towards Parent Company (Quarter)
0.02B-0.01B-0.01B-0.02B0.01B-0.01B-0.04B-0.02B0.02B-0.03B-0.03B-0.03B0.03B-0.05B-0.04B-0.05B0.05B-0.04B-0.20B-0.05B
Net Income towards Common Stockholders (Quarter)
0.02B-0.01B-0.01B-0.02B0.01B-0.01B-0.04B-0.02B0.02B-0.03B-0.03B-0.03B0.03B-0.05B-0.04B-0.05B0.05B-0.04B-0.20B-0.05B
Additional items
EPS (Basic) (Quarter)
0.05-0.03-3.08-0.060.04-0.03-9.49-0.080.00B-0.07-5.08-4.330.00B-6.42-5.16-7.116.96-0.05-0.22-0.05
EPS (Weighted Average and Diluted) (Quarter)
0.00B0.00B0.00B
Shares Outstanding (Weighted Average) (Quarter)
0.34B0.33B0.00B0.31B0.31B0.29B0.00B0.31B0.00B0.39B0.01B0.01B0.00B0.01B0.01B0.01B0.01B0.92B0.92B0.93B
Shares Outstanding (Diluted Average) (Quarter)
0.00B0.00B0.00B
EBITDA (Quarter)
-0.02B-0.02B-0.05B-0.02B-0.01B-22571.90B-0.08B-22621.78B-0.02B-0.03B-0.03B-0.03B-0.03B-0.04B-0.14B-44375124102.22B-0.05B-46.37-0.20B-0.05B
Interest Expenses (Quarter)
0.00B0.00B0.00B0.00B-0.00B